Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04827459 · ClinicalTrials.gov registry record · NA

Sleep Coach: A Mobile App to Address Insomnia Symptoms Among Cancer Survivors

A NA study of Breast Cancer and Prostate Cancer, sponsored by University of Michigan Rogel Cancer Center.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT04827459 is a NA study of Breast Cancer and Prostate Cancer that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 30 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04827459, a NA study of Breast Cancer and Prostate Cancer, has completed, sponsored by University of Michigan Rogel Cancer Center.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This clinical trial will evaluate the adherence, usefulness, satisfaction and effect size for the Sleep Coach app as an intervention for insomnia in 30 adult post-treatment cancer survivors.

Interventions

  • BEHAVIORAL Sleep Coach App

Study Locations (1)

Michigan

  • University of Michigan Rogel Cancer Center - Ann Arbor

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2021-05-12
Est. Completion 2022-08-08
Phase NA

What the Registry Record Tells You About NCT04827459

The ClinicalTrials.gov registry entry for NCT04827459 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Sleep Coach App is the first listed.

NCT04827459 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT04827459 about?

NCT04827459 is a clinical study titled "Sleep Coach: A Mobile App to Address Insomnia Symptoms Among Cancer Survivors". This clinical trial will evaluate the adherence, usefulness, satisfaction and effect size for the Sleep Coach app as an intervention for insomnia in 30 adult post-treatment cancer survivors.

What is the current status of trial NCT04827459?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2021-05-12. Estimated completion is 2022-08-08.

What conditions does trial NCT04827459 study?

This clinical trial studies the following conditions: Breast Cancer, Prostate Cancer, Insomnia, Colon Cancer.

What interventions are being tested in trial NCT04827459?

The interventions under investigation include: Sleep Coach App (BEHAVIORAL).

Who is sponsoring clinical trial NCT04827459?

This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04827459 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.